(19)
(11) EP 1 811 036 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.09.2011 Bulletin 2011/38

(45) Mention of the grant of the patent:
01.06.2011 Bulletin 2011/22

(21) Application number: 06027072.5

(22) Date of filing: 22.02.2000
(51) International Patent Classification (IPC): 
C12N 15/85(2006.01)
A61K 47/48(2006.01)
A61K 9/127(2006.01)
A61K 48/00(2006.01)

(54)

Antibody fragment-targeted immunoliposomes for systemic gene delivery

Immunoliposome mit einem Targeting-Antikörperfragment zur systemischen Genverabreichung

Immunolipsomes ciblés sur un fragment d'anticorps utiles pour l'administration systemique d'un gène


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 22.02.1999 US 121133 P

(43) Date of publication of application:
25.07.2007 Bulletin 2007/30

(62) Application number of the earlier application in accordance with Art. 76 EPC:
00915818.9 / 1154756

(73) Proprietors:
  • Georgetown University
    Washington, DC 20057 (US)
  • SynerGene Therapeutics, Inc.
    Potomac, MD 20854-3963 (US)

(72) Inventors:
  • Alexander, William
    Rockville, MD 20851 (US)
  • Xu, Liang
    Ann Arbor, MI 48103-8818 (US)
  • Huang, Cheng-Cheng
    Fairfax, VA 22031-3021 (US)
  • Tang, WenHua
    Ann Arbor, MI 48103-8818 (US)
  • Chang, Esther H.
    Potomoac, MD 20854-4438 (US)

(74) Representative: Daniels, Jeffrey Nicholas et al
Page White & Farrer Bedford House John Street
London WC1N 2BF
London WC1N 2BF (GB)


(56) References cited: : 
WO-A-99/25320
WO-A1-99/25320
WO-A1-00/15649
   
  • HAMADA K ET AL: "Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells" GYNECOLOGIC ONCOLOGY 1996 UNITED STATES, vol. 63, no. 2, 1996, pages 219-227, XP002437975 ISSN: 0090-8258
  • DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; March 1994 (1994-03), ZHANG W W ET AL: "High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus." XP002437978 Database accession no. NLM7621238 & CANCER GENE THERAPY MAR 1994, vol. 1, no. 1, March 1994 (1994-03), pages 5-13, ISSN: 0929-1903
  • HAMADA K ET AL: "Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro." GYNECOLOGIC ONCOLOGY MAR 1996, vol. 60, no. 3, March 1996 (1996-03), pages 373-379, XP002437976 ISSN: 0090-8258
  • XU L ET AL: "Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro" HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, vol. 8, no. 4, 1 March 1997 (1997-03-01), pages 467-475, XP002098089 ISSN: 1043-0342
  • DE KRUIF J ET AL: "Biosynthetically lipid-modified human scFv fragments from phage display libraries as targeting molecules for immunoliposomes" FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 3, no. 399, 16 December 1996 (1996-12-16), pages 232-236, XP002075140 ISSN: 0014-5793
  • COMPAGNON B ET AL: "ENHANCED GENE DELIVERY AND EXPRESSION IN HUMAN HEPATOCELLULAR CARCINOMA CELLS BY CATIONIC IMMUNOLIPOSOMES" JOURNAL OF LIPOSOME RESEARCH, TAYLOR & FRANCIS, PHILADELPHIA, PA, US, vol. 7, no. 1, 1997, pages 127-141, XP000682912 ISSN: 0898-2104
  • YOSHIDA J ET AL: "SIMPLE PREPARATION AND CHARACTERIZATION OF CATIONIC LIPOSOMES ASSOCIATED WITH A MONOCLONAL ANTIBODY AGAINST GLIOMA-ASSOCIATED ANTIGEN (IMMUNOLIPOSOMES)" JOURNAL OF LIPOSOME RESEARCH, TAYLOR & FRANCIS, PHILADELPHIA, PA, US, vol. 5, no. 4, January 1995 (1995-01), pages 981-995, XP000558625 ISSN: 0898-2104
  • KOBATAKE E ET AL: "A FLUOROIMMUNOASSAY BASED ON IMMUNOLIPOSOMES CONTAINING GENETICALLYENGINEERED LIPID-TAGGED ANTIBODY" ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 69, no. 7, 1 April 1997 (1997-04-01), pages 1295-1298, XP000689729 ISSN: 0003-2700
  • JIANG A ET AL: "Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies" JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 72, no. 12, December 1998 (1998-12), pages 10148-10156, XP002103152 ISSN: 0022-538X
  • CELL, vol. 45, 1986, pages 229-236,
  • 'MOLECULAR BIOLOGY AND BIOTECHNOLOGY. ED: MEYERS', WILEY-VCH page 609
  • 'VIROLOGY ED: FIELDS', RAVEN PRESS pages 210 - 212
  • MICROBIOLOGICAL REVIEWS, vol. 46, 1982, pages 377-383,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).